Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date Location
Dendreon FDA Deadline Set For May 1 Luke Timmerman 11/20/09 Seattle
Alder’s Breakout $1B Deal, Kineta Teams With UW on Vaccines, Verathon Gets Acquired, & More Seattle-Area Life Sciences News Luke Timmerman 11/12/09 Seattle
BioVex Nails Down Another $30M To Finish Pivotal Study of Cancer-Killing Virus Luke Timmerman 11/10/09 Boston
Tokai Pushes Edge With Three-Pronged Attack on Prostate Cancer Luke Timmerman 11/10/09 Boston
Dendreon Burns $28M in Q3 Luke Timmerman 11/09/09 Seattle
Dendreon Files FDA Application, DxBox Reaches Turning Point, ISB to Do 100 Genomes, & More Seattle-Area Life Sciences News Luke Timmerman 11/05/09 Seattle
Dendreon Files Provenge Application to FDA Ahead of Schedule, Now It’s Time to Wait Luke Timmerman 11/02/09 Seattle
Sequel Pharmaceuticals’ CEO on How to Start a Biotech and Sell it For a Bundle, and Repeat Luke Timmerman 10/28/09 San Diego
Dendreon Recruits Aces to Board, Amgen Seeks to Raise Hit Rate, Lee Hood Startup Gets $30M, & More Seattle-Area Life Sciences News Luke Timmerman 10/15/09 Seattle
Five Red Flags to Watch Out For in a Biotech, From Dendreon Co-Founder Chris Henney Luke Timmerman 10/15/09 Seattle
Six Tips on How to Spot a Winning Biotech, From Dendreon Co-Founder Chris Henney Luke Timmerman 10/14/09 Seattle
Dendreon Recruits Genentech CEO, Former Lilly Manufacturing Chief to Board Luke Timmerman 10/09/09 Seattle
How Much Do Biotech Workers Really Earn? Maybe Not as Much as Politicians Say Luke Timmerman 10/02/09 Seattle
AVI Settles In, ZymoGenetics MS Drug Fails, Dendreon’s FDA Filing Set for Mid-November & More Seattle-Area Life Sciences News Luke Timmerman 10/01/09 Seattle
Lee Hood’s New Idea, Calypso Scores $50M, Novo’s Historic Mistake Pays Off for Seattle, & More Seattle-Area Life Sciences News Luke Timmerman 09/25/09 Seattle
Dendreon to Turn in Provenge Application to FDA in Mid-November Luke Timmerman 09/24/09 Seattle
Five Big Questions For Dendreon’s Analyst Day Luke Timmerman 09/24/09 Seattle
The Seattle Biotech Survival Index: Companies Bounce Back in Mid-2009 Luke Timmerman 09/22/09 Seattle
Cell Therapeutics Nabs $30M, Rick Klausner on Vaccines, Targeted Growth Tinkers With Algae Genes, & More Seattle-Area Life Sciences News Luke Timmerman 08/20/09 Seattle
Seattle Genetics Recruits at Warp Speed, Amgen Passes Cancer Test, Stephen Friend’s Adventure & More Seattle-Area Life Sciences News Luke Timmerman 08/13/09 Seattle
Dendreon Ends June with $287M Cash Luke Timmerman 08/11/09 Seattle
Dendreon Will Build Manufacturing Plant in Georgia Eric Hal Schwartz 08/10/09 Seattle
AVI Bolts to Seattle, OncoGenex Escapes Dendreon’s Shadow, Buddhists Helping Biotech, & More Seattle-Area Life Sciences News Luke Timmerman 08/06/09 Seattle
OncoGenex, Toiling in Dendreon’s Shadow, Scopes Out Partners For Prostate Cancer Drug Luke Timmerman 08/05/09 Seattle
AVI Biopharma Bolts from Portland to Seattle to Tap Biotech Talent Luke Timmerman 07/30/09 Seattle
Dendreon’s Former Boss Predicts Takeover, Covance Buys Merck Lab, How NanoString Got $30M, & More Seattle-Area Life Sciences News Luke Timmerman 07/30/09 Seattle
Dendreon May Not Survive Its Success: Q&A with Founder Chris Henney, Part 2 Luke Timmerman 07/28/09 Seattle
Dendreon May Not Survive Its Success: Q&A with Founder Chris Henney, Part 1 Luke Timmerman 07/27/09 Seattle
ZymoGenetics Picks Up Mojo, Dendreon Looks Southeast, Cell Therapeutics Raises Dough & More Seattle-Area Life Sciences News Luke Timmerman 07/23/09 Seattle
Dendreon Scouts for Next Manufacturing Plant, Probably Far From Salmon and Evergreens Luke Timmerman 07/22/09 Seattle
Page 1 of 4 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.